Tempus AI (NASDAQ:TEM) COO Ryan Fukushima Sells 10,099 Shares

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 10,099 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $65.54, for a total value of $661,888.46. Following the completion of the transaction, the chief operating officer owned 829,081 shares of the company’s stock, valued at $54,337,968.74. This trade represents a 1.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Ryan Fukushima also recently made the following trade(s):

• On Monday, November 3rd, Ryan Fukushima sold 5,000 shares of Tempus AI stock. The shares were sold at an average price of $89.03, for a total value of $445,150.00.
• On Monday, October 6th, Ryan Fukushima sold 5,000 shares of Tempus AI stock. The shares were sold at an average price of $92.32, for a total value of $461,600.00.

Tempus AI Trading Down 4.9%

Shares of TEM stock traded down $3.40 during trading hours on Thursday, hitting $65.69. 7,149,431 shares of the company were exchanged, compared to its average volume of 11,236,510. The firm has a market cap of $11.69 billion, a PE ratio of -55.20 and a beta of 4.86. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $104.32. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. The firm has a fifty day moving average of $84.42 and a 200 day moving average of $71.91.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. The company had revenue of $334.21 million for the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. Tempus AI’s revenue for the quarter was up 84.7% on a year-over-year basis. During the same quarter last year, the business earned ($0.46) EPS. Tempus AI has set its FY 2025 guidance at EPS. Analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

TEM has been the subject of several research reports. Guggenheim boosted their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 26th. TD Cowen lowered shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price on the stock. in a report on Tuesday, October 21st. Needham & Company LLC increased their price target on Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group reduced their price objective on Tempus AI from $110.00 to $95.00 and set a “buy” rating on the stock in a research note on Wednesday, November 5th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $80.00.

Hedge Funds Weigh In On Tempus AI

A number of institutional investors and hedge funds have recently bought and sold shares of TEM. Cranbrook Wealth Management LLC bought a new position in shares of Tempus AI during the 3rd quarter valued at about $25,000. Concord Wealth Partners lifted its stake in Tempus AI by 308.0% during the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock valued at $26,000 after purchasing an additional 308 shares during the last quarter. JPL Wealth Management LLC bought a new stake in Tempus AI during the third quarter worth approximately $26,000. GAMMA Investing LLC bought a new stake in Tempus AI during the third quarter worth approximately $28,000. Finally, Allworth Financial LP grew its position in Tempus AI by 5,000.0% in the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after buying an additional 450 shares during the last quarter. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.